IRIDEX Reaches Milestone of 1000th Cyclo G6 System Shipped

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
29
IRIDEX Reaches Milestone of 1000th Cyclo G6 System Shipped

MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX ) today announced that in the second quarter of 2018 it has shipped the 1,000th unit of its Cyclo G6™ Laser System, which utilizes the Company’s proprietary MicroPulse® technology for the treatment of glaucoma. Dr. Ryo Taniguchi, of the Taniguchi Eye Clinic in Japan, Kyoshu Saga Prefecture, was the recipient of the 1,000 th system. “MicroPulse Laser therapy is a new and very promising technology in Japan, providing an effective and non-incisional treatment for glaucoma patients with a range of stages of the disease. The earlier clinical research performed in US, Europe and Asia showed that MicroPulse is safe and effective in IOP reduction and medication use decrease, and my clinical findings confirm the previous studies’ results.  As one of the first sites in Japan to use the Cyclo G6 for glaucoma treatment, we have seen significant benefits. Even patients with previous intraocular surgeries experienced positive results,” said Makoto Aihara MD, PhD, Professor and Chair, University of Tokyo. The Cyclo G6 system is supported by a growing body of clinical evidence and extensive validation in the field for the treatment of glaucoma. Physicians worldwide have adopted the Cyclo G6 because it is safe, minimally invasive, non-incisional, repeatable and durable. Moreover, the Cyclo G6 provides physicians and the healthcare system a cost-effective solution for the treatment of glaucoma across the full continuum of care – from early to late stage glaucoma. More than 80,000 patients worldwide have been treated with the Cyclo G6 system. “In my opinion, MicroPulse Laser therapy shifts the paradigm of glaucoma treatments in Japan. It provides a new choice for a safe, effective, and non-incisional treatment on various glaucoma patients with mild, moderate, and late stage disease. The MicroPulse procedure can be performed on a wide variety of patients not responding to medications or not qualified for incisional surgeries. Recent industry meetings and clinical presentations of leading physicians using the MicroPulse procedure in the United States, Europe and Asia have demonstrated and proven that fact. My initial clinical experience with it confirms these findings,” commented Dr. Ryo Taniguchi. “We are delighted to achieve this exciting milestone in the commercialization of our Cyclo G6 laser system, as it not only demonstrates the traction the platform is gaining worldwide, but highlights the progress we have made in transforming our business to delivering a compelling and proven treatment alternative for patients suffering from glaucoma,” said William Moore, Chief Executive Officer of IRIDEX. About IRIDEX IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit iridex.com. Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, including those statements concerning future sales of Company products and industry trends. These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors, including the Company’s ability to execute on its strategic goals, market adoption of its products and industry developments. Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December 30, 2017, and Quarterly Reports on Form 10-Q for subsequent fiscal quarters, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated. Media Contact: Jamie Hall Pascale Communications, LLC. 724.417.0167 jamie@pascalecommunications.com Investor Relations Contact Lynn Pieper Lewis or Leigh Salvo 415.937.5404 investors@iridex.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phoenix Scholar Examines AI and Institutional Trust

Updated Category News Views 2

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Continue Reading
Mastering Packaging Costs: Beyond the Box Price

Updated Category News Views 5

Peeling Back the Layers of Packaging Costs Packaging's a bit like an onion—every layer you peel back reveals another cost you didn’t see at first glance. Folks in the know, like Kyle Reger of Jamestown Container Companies, are flipping the script on how we approach packaging expenses. It's not just about snagging the cheapest box on the shelf anymore. There's a whole...

Continue Reading
NCICU's Digital Boost for NC Transfer Students

Updated Category News Views 4

New Platform Eases the Transfer Struggle They’ve finally cooked up something good for the college crowd in North Carolina. The NCICU, with the NCCCS, has rolled out a platform called Transfer Pathways to simplify students' path from two-year to four-year schools. This ain't just a tweak—it's backed by a hefty $2 million in grants. Hats off to those...

Continue Reading
Toyland 2026: Blain's 'Open The Magic' Event Marks 69 Years

Updated Category News Views 7

There's something about nostalgia that hooks you right in the gut, like remembering those jittery walks through Blain's Farm & Fleet's Toyland aisles. If there's one thing these folks know, it's how to spark holiday cheer deep in the Midwest bones. Here we are, just before the dust settles on another year, and Blain's is rolling out its 69th Toyland party—a cherished...

Continue Reading
Jiangxi Dialogues: Youths Forge Global Ties in 2026

Updated Category News Views 1

Bringing Global Youth to the Table In the heart of Jiangxi, China, young minds from across the globe gathered not just to chat but to shape the future. A bunch who only a decade ago might have been ignored in such circles are now leading discussions, and they’ve kicked off their powwow on September 22, 2026, with a bang in Nanchang. What’s the Agenda? Imagine more...

Continue Reading
Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Updated Category News Views 1

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Continue Reading
Zenni and Chase Stokes Foster Student Wellbeing in NYC

Updated Category News Views 3

Picture this: near 300 high schoolers milling around, glancing through shiny new glasses from the Zenni x Chase Stokes collection. In the heart of New York City, these kids are getting a double-dose of care that's all too rare—free vision screenings paired with mental health support. It's the kind of collaboration that shows you what's possible when a company, an actor,...

Continue Reading
Amap, Sands China Unleash Tutu Robots for Resort Duty

Updated Category News Views 1

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...

Continue Reading
Korea Tourism’s Quiz Offers Free Trip Sweepstakes

Updated Category News Views 4

A Shot at Adventure Without Opening Your Wallet Let me tell you, Korea's got a way of sweeping folks off their feet with a little something for everyone—from a foodie’s paradise to history buff heaven. The Korea Tourism Organization's (KTO) New York Office is lighting up the stage with a slick offer: enter a quiz on their website and you might just be jetting off to...

Continue Reading
ODL’s Impact Door System Wins 2026 Editors' Pick

Updated Category News Views 5

Award-Winning Entry: ODL's Latest Triumph In a world where first impressions count, ODL, Inc. sure knows how to leave a mark. Their Impact Rated Fiberglass Entry System with Keystone Frame Technology snagged a notable spot in the 2026 Best of Products Awards by Architect's Newspaper. Let me tell you, in the building biz, accolades like these are no small potatoes. To get...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating Ruder Finn's Recognition as a Top Workplace

Updated Category News Views 144

Ruder Finn Recognized as a Top Workplace Ruder Finn, a prominent independent global communications and integrated marketing agency, has received accolades for the second consecutive year by being named one of Medical Marketing and Media's (MM+M) Best Places to Work in the 'Large Companies' category. This recognition highlights the agency's commitment to fostering an...

Continue Reading
Innovative Strategies to Control Hospital Infections Revealed

Updated Category News Views 263

Discovering Advanced Solutions for Hospital Infection Control In the world of healthcare, maintaining stringent infection control measures is paramount, especially within hospital settings. ActivePure Medical, a renowned division of AP Sciences Group, LLC, is at the forefront of this vital mission. With its innovative continuous air and surface decontamination technology,...

Continue Reading
AstraZeneca's TAGRISSO Approval: A New Hope for Lung Cancer Patients

Updated Category News Views 212

AstraZeneca just punched a ticket in the oncology world with its FDA approval of TAGRISSO (osimertinib) for treating lung cancer. This isn’t your run-of-the-mill approval; it's a big deal for adult patients facing Stage III epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC). We're talking about folks who can't undergo surgery and...

Continue Reading
Partnership Insights: NEO Battery and North American Drone Maker

Updated Category News Views 127

NEO Battery's Significant Offtake Agreement NEO Battery Materials Ltd. is making waves in the battery industry with a recent agreement that is set to enhance its position in the market. This exciting development includes a multi-year offtake agreement with a North American lithium-ion battery company, aimed at producing high-performance silicon battery materials. The deal...

Continue Reading
Core Scientific's September 2024 Updates Reflect Growth Strategy

Updated Category News Views 60

Core Scientific's September 2024 Production and Operations Overview Core Scientific, Inc. (Nasdaq: CORZ), a recognized leader in digital infrastructure for bitcoin mining and high-performance computing, has recently shared its production and operations updates for September 2024. The company's operations are noteworthy, showcasing ambitious plans and significant...

Continue Reading